Humulin Injection, Suspension
NDC Package 0002-8803-59

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Humulin (insulin human) injection is combination isophane/regular insulin is used with a proper diet and exercise program to control high blood sugar in people with diabetes. This formulation utilizes a injection, suspension delivery system. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-8803 and is authorized under FDA application BLA019717.

Identification & Billing

NDC Package Code
0002-8803-59
Package Description
5 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE (0002-8803-01)
Product Code
0002-8803
11-Digit Billing Format
00002880359
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 106892 - HumuLIN 70/30 Injectable Suspension
  • RxCUI: 106892 - insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]
  • RxCUI: 106892 - Humulin 70/30 Injectable Suspension
  • RxCUI: 311048 - insulin, human isophane / insulin regular 70/30 Injectable Suspension
  • RxCUI: 311048 - insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension

Clinical Specifications

Proprietary Name
Humulin 70/30 Kwikpen
Non-Proprietary Name
Insulin Human
Substance Name
Insulin Human
Dosage Form
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Administration Route
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
INSULIN HUMAN 100 [iU]/mL
Pharmacologic Class
Usage Information
Combination isophane/regular insulin is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a mixture of 70% intermediate-acting insulin (isophane) and 30% short-acting insulin (regular). It starts to work as quickly as regular insulin but lasts longer. This insulin product works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product may be used alone or with other oral diabetes drugs (such as metformin).

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
Product Type
Human Otc Drug
FDA Application #
BLA019717
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
11-07-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-8803-59 identifies a specific commercial package of 5 syringe in 1 carton / 3 ml in 1 syringe (0002-8803-01) of Humulin 70/30 Kwikpen, a human over the counter drug labeled by Eli Lilly And Company. This injection, suspension is formulated for subcutaneous use and contains insulin human as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eli Lilly And Company on November 07, 2013. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Combination isophane/regular insulin is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a mixture of 70% intermediate-acting insulin (isophane) and 30% short-acting insulin (regular). It starts to work as quickly as regular insulin but lasts longer. This insulin product works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product may be used alone or with other oral diabetes drugs (such as metformin).

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002880359. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-8803-59
11-Digit CMS (5-4-2)
00002-8803-59

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.